Jonathan Schechter Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

Jonathan Schechter is Director of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 192,500 shares of PMCB, which is worth approximately $152,075. The most recent transaction as insider was on Jan 07, 2026, when has been sold 20,000 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $16,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K

n/a 3M change

n/a 12M change

Total Value Held $152,075

JONATHAN SCHECHTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	BUY Open market or private purchase	$16,800 $0.84 p/Share	20,000 Added 9.41%	192,500 Common Stock
Jan 06 2026	BUY Open market or private purchase	$15,800 $0.79 p/Share	20,000 Added 10.39%	172,500 Common Stock
Jan 05 2026	BUY Open market or private purchase	$15,600 $0.78 p/Share	20,000 Added 11.59%	152,500 Common Stock
Dec 12 2025	SELL Payment of exercise price or tax liability	$68,850 $1.02 p/Share	67,500 Reduced 33.75%	132,500 Common Stock
Dec 12 2025	BUY Grant, award, or other acquisition	-	150,000 Added 42.86%	200,000 Common Stock

Also insider at

SNPX

Synaptogenix, Inc. Healthcare

Director

OBLG

Oblong, Inc. Technology

Director